Model Number 3000TFX |
Device Problems
Gradient Increase (1270); Inadequacy of Device Shape and/or Size (1583); Insufficient Information (3190)
|
Patient Problems
Dyspnea (1816); Insufficient Information (4580)
|
Event Date 02/25/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
The subject device is not available; was discarded.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
It was learned through the implant patient registry that a 3000tfx 19mm bioprosthetic aortic valve, implanted for three (3) years and seven (7) months, was explanted due to unknown reasons.The explanted device was replaced with a 3300tfx 21mm bioprosthetic valve.Patient post procedure in recovery.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
|
|
Event Description
|
It was learned through the implant patient registry that a (b)(6) bioprosthetic aortic valve, implanted for three (3) years and seven (7) months, was explanted due to its relatively small size for the patient body habitus resulting in slightly elevated gradients.The device was replaced with a 21mm 3300tfx valve.The patient was discharged on pod#40.Per medical records, the patient presented with shortness of breath and was found with severe stenosis of the native mv.She underwent a redo sternotomy.Intraoperatively, the mitral valve was heavily calcified.Visualization was somewhat compromised by the prior 19mm 3000tfx aortic prosthesis and given that it was a relatively small prosthesis with slightly elevated gradients, it was decided to explant it.Mvr was performed with a 25mm non-edwards valve.Avr was performed with a larger size 21mm 3300tfx valve which was seated down nicely in place and secured with a cor-knot device.An incision was made in the noncoronary sinus down to the top of the left non-commissure to pass the valve through the sinotubular junction.A segment of a bovine pericardium was used to perform aortic root enlargement.Post cardiopulmonary bypass, both prostheses were well-seated with appropriate gradients.There were no paravalvular leaks on the aortic valve.The patient tolerated the procedure well and was transferred to the icu in critical condition.Per the pathology report, the cusps of the explanted valve were intact and freely moveable without any plaques, thrombi, vegetations, or tears.There was a minimal amount of tan soft-tissue overgrowth on the sewing ring.
|
|
Manufacturer Narrative
|
Updated sections: b5, b6, b7, d4 expiration date, h4, h6 component codes, health effect - clinical code, device code(s), type of investigation, investigation findings, and investigation conclusions.The device history record (dhr) was not reviewed as the reported event does not allege a malfunction that could be related to an edwards manufacturing deficiency and/or one was not confirmed through investigation.Patient prosthesis mismatch (ppm) is present when the effective orifice area of the inserted prosthetic valve is too small in relation to body size.Its main hemodynamic consequence is to generate higher than expected gradients through a normally functioning prosthetic valve.Ppm has been shown to be associated with worse hemodynamic function, less regression of left ventricular hypertrophy, more cardiac events, and lower survival.Through further investigation, it was determined that the root cause of this event occurred due to procedural factors.
|
|
Search Alerts/Recalls
|
|